Earlier breast development, pubic hair development, menarche with methyl paraben exposure

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Family Functioning …

Harmful effects for sugar-sweetened beverages when excess energy from sugar added to diet

Patients reporting cost-related underuse more likely to have poor glycemic control

Significant additive interaction identified for night shift work, unhealthy lifestyle for female nurses

Findings observed for veterans with diabetes and concomitant chronic kidney disease

Peripheral CT indices address risk for fracture contributed by changes in bone microarchitecture

Frequent family dinners tied to higher-quality dietary intake, regardless of level of family functioning

Report provides guidance on reducing CV risk in patients with T2DM and atherosclerotic CV disease

Breastfeeding lowers risk in those large for gestational age, but only without maternal diabetes